Orthopedic surgical reagent Aurora Exo Series Ortho®

for tissue engineeringlyophilized

Product Overview
Aurora Exo Series Ortho is a next-generation lyophilized exosome product engineered for bone and cartilage regenerative applications. The formulation concentrates osteogenic and chondrogenic signals to support targeted tissue repair while offering improved stability and simplified storage compared with conventional MSC-derived exosomes.

Key Features

• 5 billion standardized exosome particles per vial
• Storable at +4°C (no -80°C cold chain required)
• Ready-to-use activator system included
• Format specifically developed for orthopedic use

Why Aurora Exo Ortho? Targeted Regeneration
Derived from cells directed toward osteogenic and chondrogenic lineages, Aurora Exo Series Ortho is enriched with tissue-specific biological signals to support bone and cartilage regeneration more selectively than general-purpose MSC-derived exosomes.

Lyophilized Technology
Lyophilization eliminates the need for ultra-low temperature logistics. The product is stable under refrigerated conditions (+4°C), facilitating storage, transport and on-demand clinical use.

Standardized Dosage
Each vial contains a calibrated dose of 5 billion exosome particles, increasing standardization and predictability for clinical protocols.

Ready to Use
Reconstitution is performed within minutes using the provided activator solution; the preparation is suitable for use in clinical or operating room settings.

Application Areas

• Osteoarthritis — support for cartilage matrix and joint biology
• Osteochondral lesions — simultaneous support for cartilage and subchondral bone regeneration
• Bone defects — adjunctive use with grafts or synthetic scaffold systems
• Spinal fusion — biological support when added to graft materials
• Meniscus and labrum injuries — minimally invasive biological augmentation

Technical Specifications

• Product line: Aurora Exo Series Ortho®
• Format: Lyophilized exosomes (vial/tray preparation)
• Dosage: 5 billion standardized exosome particles per vial
• Storage conditions: +4°C (refrigerated), no -80°C required
• Presentation: Ready-to-use after reconstitution with provided activator solution
• Intended use: Orthopedic regenerative applications (bone and cartilage focused)
• Advantages: Engineered for osteogenic and chondrogenic tissues; standardized dosage; extended shelf life via lyophilization